Loading…

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions

Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infe...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine 2014-04, Vol.7 (4), p.778-784
Main Authors: JI, QIAOYING, HUANG, BIFEI, WANG, MAOFENG, REN, ZHAOXIANG, ZHANG, SHA, ZHANG, YONGJUN, SHENG, LIJIAN, YU, YAYAO, JIANG, JINWEN, CHEN, DEBAO, YING, JUN, YU, JIONG, QIU, LIUYI, WAN, RUGEN, LI, WEIMIN
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663
cites cdi_FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663
container_end_page 784
container_issue 4
container_start_page 778
container_title Experimental and therapeutic medicine
container_volume 7
creator JI, QIAOYING
HUANG, BIFEI
WANG, MAOFENG
REN, ZHAOXIANG
ZHANG, SHA
ZHANG, YONGJUN
SHENG, LIJIAN
YU, YAYAO
JIANG, JINWEN
CHEN, DEBAO
YING, JUN
YU, JIONG
QIU, LIUYI
WAN, RUGEN
LI, WEIMIN
description Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infectious PE and malignant PE (MPE) by measuring two major acute phase response biomarkers: prealbumin (PA) and C-reactive protein (CRP). The study was a prospective trial involving 151 patients who were diagnosed with infectious PE or MPE. Patients with infectious PE were divided into two subgroups: tuberculous PE (TBPE) and parapneumonic PE (PNPE). A further 58 patients with PEs that showed no evidence of MPE, TBPE or PNPE were classified as the chronic non-specific PE (NSPE) group. Demographic characteristics and pleural fluids of the subjects were collected consecutively. The discriminative properties of pleural fluid routine biochemistries, and PA and CRP were evaluated. PA, CRP and classical fluid parameters were also applied to classify patients with infectious PE and MPE. Receiver operating characteristics (ROC) analysis established the cutoffs of PA and CRP for discriminating between groups. Pleural fluid PA levels were significantly higher in the MPE group (n=47) than in the infectious PE group (n=104). Pleural fluid CRP levels were significantly higher in the infectious PE group than in the MPE group. Pleural fluid PA levels were identified to be moderately negatively correlated with CRP levels in the MPE group, with a statistically significant correlation coefficient of −0.352. The ROC curve showed that the sensitivity and specificity of PA for the diagnosis of MPE were 0.851 and 0.548, respectively, at the cutoff of 28.3 mg/l. The area under the curve (AUC) was 0.784 (95% CI, 0.707-0.861). Using CRP as a diagnostic parameter resulted in an comparable AUC of 0.810 (95% CI, 0.736-0.885), at the cutoff of 35.2 mg/l. Combinations of PA and CRP resulted in incrementally discriminating values for MPE, with a sensitivity of 0.617 and a specificity of 0.903. The measurement of PA and CRP levels in pleural fluid may be a useful adjunctive test in PE, as a potential differentiator between infectious PE and MPE.
doi_str_mv 10.3892/etm.2014.1503
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3961133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A410768960</galeid><sourcerecordid>A410768960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663</originalsourceid><addsrcrecordid>eNptkktr3DAUhU1paEKSZbfF0EW78URvy5tCGPqCQLpo10K2ryYKsuRadiD0z_e6Mx2SUtvItvTdIx3pFMVrSjZcN-wK5mHDCBUbKgl_UZzRumEVJVS-PHyTRtPT4jLne4KXVFRr-ao4ZUKphnF-Vvz6FmCZbChdWHxfjhPY0C6Dj6WNfbmt8L-b_QPgSJoBu_GZ76DsvXMwQZw91vbe7mLKPpfJIeAAS9KS_0gMNvhdtHEux8NM4NySfYr5ojhxNmS4PLzPix-fPn7ffqlubj9_3V7fVJ2kYq5azSVjogWmJZeqhVpJ5ywVHERLFFOtEHXniHW6p5RztNk1gvbMKd46pfh58WGvOy7tAH2Hq8Z1mHHyg50eTbLePB-J_s7s0oPhjVoFUeD9QWBKPxfIsxl87iAEGwF9GqqZkg0XtUb07T_ofVqmiPYMbTgejebiCbWzAQzuWMJ5u1XUXAtKaqUbRZDa_IfCu4fBdymC89j_rKDaF3RTynkCd_RIiVkDYzAwZg2MWQOD_JunG3Ok_8YDgXd7II94lr5P-cigUkXqighs0fdvk5_JMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1931018348</pqid></control><display><type>article</type><title>Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions</title><source>PubMed Central</source><creator>JI, QIAOYING ; HUANG, BIFEI ; WANG, MAOFENG ; REN, ZHAOXIANG ; ZHANG, SHA ; ZHANG, YONGJUN ; SHENG, LIJIAN ; YU, YAYAO ; JIANG, JINWEN ; CHEN, DEBAO ; YING, JUN ; YU, JIONG ; QIU, LIUYI ; WAN, RUGEN ; LI, WEIMIN</creator><creatorcontrib>JI, QIAOYING ; HUANG, BIFEI ; WANG, MAOFENG ; REN, ZHAOXIANG ; ZHANG, SHA ; ZHANG, YONGJUN ; SHENG, LIJIAN ; YU, YAYAO ; JIANG, JINWEN ; CHEN, DEBAO ; YING, JUN ; YU, JIONG ; QIU, LIUYI ; WAN, RUGEN ; LI, WEIMIN</creatorcontrib><description>Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infectious PE and malignant PE (MPE) by measuring two major acute phase response biomarkers: prealbumin (PA) and C-reactive protein (CRP). The study was a prospective trial involving 151 patients who were diagnosed with infectious PE or MPE. Patients with infectious PE were divided into two subgroups: tuberculous PE (TBPE) and parapneumonic PE (PNPE). A further 58 patients with PEs that showed no evidence of MPE, TBPE or PNPE were classified as the chronic non-specific PE (NSPE) group. Demographic characteristics and pleural fluids of the subjects were collected consecutively. The discriminative properties of pleural fluid routine biochemistries, and PA and CRP were evaluated. PA, CRP and classical fluid parameters were also applied to classify patients with infectious PE and MPE. Receiver operating characteristics (ROC) analysis established the cutoffs of PA and CRP for discriminating between groups. Pleural fluid PA levels were significantly higher in the MPE group (n=47) than in the infectious PE group (n=104). Pleural fluid CRP levels were significantly higher in the infectious PE group than in the MPE group. Pleural fluid PA levels were identified to be moderately negatively correlated with CRP levels in the MPE group, with a statistically significant correlation coefficient of −0.352. The ROC curve showed that the sensitivity and specificity of PA for the diagnosis of MPE were 0.851 and 0.548, respectively, at the cutoff of 28.3 mg/l. The area under the curve (AUC) was 0.784 (95% CI, 0.707-0.861). Using CRP as a diagnostic parameter resulted in an comparable AUC of 0.810 (95% CI, 0.736-0.885), at the cutoff of 35.2 mg/l. Combinations of PA and CRP resulted in incrementally discriminating values for MPE, with a sensitivity of 0.617 and a specificity of 0.903. The measurement of PA and CRP levels in pleural fluid may be a useful adjunctive test in PE, as a potential differentiator between infectious PE and MPE.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2014.1503</identifier><identifier>PMID: 24669233</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Adenosine ; Biomarkers ; Brain cancer ; C-reactive protein ; Cardiovascular disease ; Care and treatment ; Clinical medicine ; Dehydrogenases ; Diagnosis ; Health aspects ; Laboratories ; Medical diagnosis ; Patients ; Physiological aspects ; Pleural effusion ; Pneumonia ; prealbumin ; Proteins ; Standard deviation ; Studies ; Triglycerides</subject><ispartof>Experimental and therapeutic medicine, 2014-04, Vol.7 (4), p.778-784</ispartof><rights>Copyright © 2014, Spandidos Publications</rights><rights>COPYRIGHT 2014 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2014</rights><rights>Copyright © 2014, Spandidos Publications 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663</citedby><cites>FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961133/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961133/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24669233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JI, QIAOYING</creatorcontrib><creatorcontrib>HUANG, BIFEI</creatorcontrib><creatorcontrib>WANG, MAOFENG</creatorcontrib><creatorcontrib>REN, ZHAOXIANG</creatorcontrib><creatorcontrib>ZHANG, SHA</creatorcontrib><creatorcontrib>ZHANG, YONGJUN</creatorcontrib><creatorcontrib>SHENG, LIJIAN</creatorcontrib><creatorcontrib>YU, YAYAO</creatorcontrib><creatorcontrib>JIANG, JINWEN</creatorcontrib><creatorcontrib>CHEN, DEBAO</creatorcontrib><creatorcontrib>YING, JUN</creatorcontrib><creatorcontrib>YU, JIONG</creatorcontrib><creatorcontrib>QIU, LIUYI</creatorcontrib><creatorcontrib>WAN, RUGEN</creatorcontrib><creatorcontrib>LI, WEIMIN</creatorcontrib><title>Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infectious PE and malignant PE (MPE) by measuring two major acute phase response biomarkers: prealbumin (PA) and C-reactive protein (CRP). The study was a prospective trial involving 151 patients who were diagnosed with infectious PE or MPE. Patients with infectious PE were divided into two subgroups: tuberculous PE (TBPE) and parapneumonic PE (PNPE). A further 58 patients with PEs that showed no evidence of MPE, TBPE or PNPE were classified as the chronic non-specific PE (NSPE) group. Demographic characteristics and pleural fluids of the subjects were collected consecutively. The discriminative properties of pleural fluid routine biochemistries, and PA and CRP were evaluated. PA, CRP and classical fluid parameters were also applied to classify patients with infectious PE and MPE. Receiver operating characteristics (ROC) analysis established the cutoffs of PA and CRP for discriminating between groups. Pleural fluid PA levels were significantly higher in the MPE group (n=47) than in the infectious PE group (n=104). Pleural fluid CRP levels were significantly higher in the infectious PE group than in the MPE group. Pleural fluid PA levels were identified to be moderately negatively correlated with CRP levels in the MPE group, with a statistically significant correlation coefficient of −0.352. The ROC curve showed that the sensitivity and specificity of PA for the diagnosis of MPE were 0.851 and 0.548, respectively, at the cutoff of 28.3 mg/l. The area under the curve (AUC) was 0.784 (95% CI, 0.707-0.861). Using CRP as a diagnostic parameter resulted in an comparable AUC of 0.810 (95% CI, 0.736-0.885), at the cutoff of 35.2 mg/l. Combinations of PA and CRP resulted in incrementally discriminating values for MPE, with a sensitivity of 0.617 and a specificity of 0.903. The measurement of PA and CRP levels in pleural fluid may be a useful adjunctive test in PE, as a potential differentiator between infectious PE and MPE.</description><subject>Adenosine</subject><subject>Biomarkers</subject><subject>Brain cancer</subject><subject>C-reactive protein</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Clinical medicine</subject><subject>Dehydrogenases</subject><subject>Diagnosis</subject><subject>Health aspects</subject><subject>Laboratories</subject><subject>Medical diagnosis</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Pleural effusion</subject><subject>Pneumonia</subject><subject>prealbumin</subject><subject>Proteins</subject><subject>Standard deviation</subject><subject>Studies</subject><subject>Triglycerides</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptkktr3DAUhU1paEKSZbfF0EW78URvy5tCGPqCQLpo10K2ryYKsuRadiD0z_e6Mx2SUtvItvTdIx3pFMVrSjZcN-wK5mHDCBUbKgl_UZzRumEVJVS-PHyTRtPT4jLne4KXVFRr-ao4ZUKphnF-Vvz6FmCZbChdWHxfjhPY0C6Dj6WNfbmt8L-b_QPgSJoBu_GZ76DsvXMwQZw91vbe7mLKPpfJIeAAS9KS_0gMNvhdtHEux8NM4NySfYr5ojhxNmS4PLzPix-fPn7ffqlubj9_3V7fVJ2kYq5azSVjogWmJZeqhVpJ5ywVHERLFFOtEHXniHW6p5RztNk1gvbMKd46pfh58WGvOy7tAH2Hq8Z1mHHyg50eTbLePB-J_s7s0oPhjVoFUeD9QWBKPxfIsxl87iAEGwF9GqqZkg0XtUb07T_ofVqmiPYMbTgejebiCbWzAQzuWMJ5u1XUXAtKaqUbRZDa_IfCu4fBdymC89j_rKDaF3RTynkCd_RIiVkDYzAwZg2MWQOD_JunG3Ok_8YDgXd7II94lr5P-cigUkXqighs0fdvk5_JMA</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>JI, QIAOYING</creator><creator>HUANG, BIFEI</creator><creator>WANG, MAOFENG</creator><creator>REN, ZHAOXIANG</creator><creator>ZHANG, SHA</creator><creator>ZHANG, YONGJUN</creator><creator>SHENG, LIJIAN</creator><creator>YU, YAYAO</creator><creator>JIANG, JINWEN</creator><creator>CHEN, DEBAO</creator><creator>YING, JUN</creator><creator>YU, JIONG</creator><creator>QIU, LIUYI</creator><creator>WAN, RUGEN</creator><creator>LI, WEIMIN</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140401</creationdate><title>Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions</title><author>JI, QIAOYING ; HUANG, BIFEI ; WANG, MAOFENG ; REN, ZHAOXIANG ; ZHANG, SHA ; ZHANG, YONGJUN ; SHENG, LIJIAN ; YU, YAYAO ; JIANG, JINWEN ; CHEN, DEBAO ; YING, JUN ; YU, JIONG ; QIU, LIUYI ; WAN, RUGEN ; LI, WEIMIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adenosine</topic><topic>Biomarkers</topic><topic>Brain cancer</topic><topic>C-reactive protein</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Clinical medicine</topic><topic>Dehydrogenases</topic><topic>Diagnosis</topic><topic>Health aspects</topic><topic>Laboratories</topic><topic>Medical diagnosis</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Pleural effusion</topic><topic>Pneumonia</topic><topic>prealbumin</topic><topic>Proteins</topic><topic>Standard deviation</topic><topic>Studies</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JI, QIAOYING</creatorcontrib><creatorcontrib>HUANG, BIFEI</creatorcontrib><creatorcontrib>WANG, MAOFENG</creatorcontrib><creatorcontrib>REN, ZHAOXIANG</creatorcontrib><creatorcontrib>ZHANG, SHA</creatorcontrib><creatorcontrib>ZHANG, YONGJUN</creatorcontrib><creatorcontrib>SHENG, LIJIAN</creatorcontrib><creatorcontrib>YU, YAYAO</creatorcontrib><creatorcontrib>JIANG, JINWEN</creatorcontrib><creatorcontrib>CHEN, DEBAO</creatorcontrib><creatorcontrib>YING, JUN</creatorcontrib><creatorcontrib>YU, JIONG</creatorcontrib><creatorcontrib>QIU, LIUYI</creatorcontrib><creatorcontrib>WAN, RUGEN</creatorcontrib><creatorcontrib>LI, WEIMIN</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JI, QIAOYING</au><au>HUANG, BIFEI</au><au>WANG, MAOFENG</au><au>REN, ZHAOXIANG</au><au>ZHANG, SHA</au><au>ZHANG, YONGJUN</au><au>SHENG, LIJIAN</au><au>YU, YAYAO</au><au>JIANG, JINWEN</au><au>CHEN, DEBAO</au><au>YING, JUN</au><au>YU, JIONG</au><au>QIU, LIUYI</au><au>WAN, RUGEN</au><au>LI, WEIMIN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>7</volume><issue>4</issue><spage>778</spage><epage>784</epage><pages>778-784</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>Contributed equally</notes><abstract>Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infectious PE and malignant PE (MPE) by measuring two major acute phase response biomarkers: prealbumin (PA) and C-reactive protein (CRP). The study was a prospective trial involving 151 patients who were diagnosed with infectious PE or MPE. Patients with infectious PE were divided into two subgroups: tuberculous PE (TBPE) and parapneumonic PE (PNPE). A further 58 patients with PEs that showed no evidence of MPE, TBPE or PNPE were classified as the chronic non-specific PE (NSPE) group. Demographic characteristics and pleural fluids of the subjects were collected consecutively. The discriminative properties of pleural fluid routine biochemistries, and PA and CRP were evaluated. PA, CRP and classical fluid parameters were also applied to classify patients with infectious PE and MPE. Receiver operating characteristics (ROC) analysis established the cutoffs of PA and CRP for discriminating between groups. Pleural fluid PA levels were significantly higher in the MPE group (n=47) than in the infectious PE group (n=104). Pleural fluid CRP levels were significantly higher in the infectious PE group than in the MPE group. Pleural fluid PA levels were identified to be moderately negatively correlated with CRP levels in the MPE group, with a statistically significant correlation coefficient of −0.352. The ROC curve showed that the sensitivity and specificity of PA for the diagnosis of MPE were 0.851 and 0.548, respectively, at the cutoff of 28.3 mg/l. The area under the curve (AUC) was 0.784 (95% CI, 0.707-0.861). Using CRP as a diagnostic parameter resulted in an comparable AUC of 0.810 (95% CI, 0.736-0.885), at the cutoff of 35.2 mg/l. Combinations of PA and CRP resulted in incrementally discriminating values for MPE, with a sensitivity of 0.617 and a specificity of 0.903. The measurement of PA and CRP levels in pleural fluid may be a useful adjunctive test in PE, as a potential differentiator between infectious PE and MPE.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>24669233</pmid><doi>10.3892/etm.2014.1503</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2014-04, Vol.7 (4), p.778-784
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3961133
source PubMed Central
subjects Adenosine
Biomarkers
Brain cancer
C-reactive protein
Cardiovascular disease
Care and treatment
Clinical medicine
Dehydrogenases
Diagnosis
Health aspects
Laboratories
Medical diagnosis
Patients
Physiological aspects
Pleural effusion
Pneumonia
prealbumin
Proteins
Standard deviation
Studies
Triglycerides
title Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T08%3A41%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pleural%20fluid%20prealbumin%20and%20C-reactive%20protein%20in%20the%20differential%20diagnosis%20of%20infectious%20and%20malignant%20pleural%20effusions&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=JI,%20QIAOYING&rft.date=2014-04-01&rft.volume=7&rft.issue=4&rft.spage=778&rft.epage=784&rft.pages=778-784&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2014.1503&rft_dat=%3Cgale_pubme%3EA410768960%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c514t-b835224be285356be765ffa143e4b0626b447cf0af8d1133056c941d2f63bf663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1931018348&rft_id=info:pmid/24669233&rft_galeid=A410768960&rfr_iscdi=true